Related Experiment Video
Updated: May 5, 2026

Clinical Application of Single-Surgeon, Three-Port, Laparoscopic Resection for Colorectal Cancer with Natural Orifice Specimen Extraction
Published on: March 24, 2023
Gender-based variations in clinical course, Endoscopic and histological findings of solitary rectal ulcer syndrome -
Nazish Butt1, Ghulam Mohiuddin2, Ali Akbar3
1Nazish Butt Department of Gastroenterology, Jinnah Postgraduate Medical Centre, Karachi, Pakistan.
Background And Objective:
Solitary Rectal Ulcer Syndrome (SRUS) is an uncommon, chronic disorder of the pelvic floor associated with defecatory dysfunction. This prospective observational study aimed to assess the comprehensive manifestations of SRUS with a focus on sex differences in risk factors, clinical presentation, and endoscopic and histopathological findings.
Methodology:
The study included 132 patients (81 females, 51 males) diagnosed with SRUS at a Jinnah Postgraduate Medical Centre and National Medical Centre in Pakistan between 2017 and 2024.
Results:
The most commonly affected age group was 21-30 years. Clinically, rectal bleeding was the predominant symptom in both genders (74.5% males, 71.6% females; p=0.715), followed by rectal pain (41.2% males, 48.1% females; p=0.433) and altered bowel habits (15.7% males, 16.0% females; p=0.956). Self-digitation was reported by 86.2% of males and 88.8% of females (p=0.654). Endoscopically, solitary rectal ulcer was observed in 60.7% of males and 60.4% of females (p=0.973), while proctitis was present in 58.8% of males and 59.2% of females (p=0.960). Histologically, crypt distortion was noted in 43.1% of males and 29.6% of females (p=0.113), fibromuscular obliteration in 56.8% of males and 45.6% of females (p=0.211), and surface ulceration in 47.0% of males and 45.6% of females (p=0.877). Although no statistically significant gender differences were identified, the study highlights the need for larger-scale investigations to explore these patterns further.
Conclusion:
This study shows SRUS is more common in females 81 (61%) and commonly affects those aged 21 to 30 years, 46 (34.8%) and bleeding per rectum was the most frequent presenting symptom 96 (72.7%).
More Related Videos
03:57Evaluation of the Effectiveness of Longitudinal Incision for Endoscopic Submucosal Excavation of Gastric Subepithelial Lesions
Published on: April 28, 2026
04:09The Pocket-Creation Procedure of Endoscopic Submucosal Dissection for Large Rectal Laterally Spreading Tumors
Published on: February 13, 2026
Related Concept Videos
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Assessment of the Rectum and Anus
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Ulcerative Colitis